TG Therapeutics recently completed a US$100 million share repurchase program, buying back approximately 3.5 million shares, and the Board of Directors has authorized an additional US$100 million ...
NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that it has completed its previously authorized $100 million share repurchase program, which was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback